http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-212864616-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_53d0ad267548abdc0abb9088c7e29f62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-576
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85
filingDate 2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2d9b26edce8b969c2bee7225921e832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76c9c671845c9d950efe9be9364c5062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0b53f6715fd30a702b25fc7151c22ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf82f406b88d968a720f0a0ad5cf3fff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a959418bc3c6d7ab057b374f8d447bfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_202e7c84de9d295d5fa699f037eee25d
publicationDate 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-212864616-U
titleOfInvention Quantitative enzyme immunoassay kit for pre-S1 antibody of hepatitis B virus
abstract The utility model discloses a hepatitis B virus pre-S1 antibody quantitative enzyme immunoassay kit, which comprises: the kit comprises a kit body, a kit cover detachably connected with the kit body, a preS1 antigen-coated enzyme-labeled reaction plate arranged in the kit body, a sample diluent reagent bottle, a washing liquid reagent bottle, an HRP enzyme-labeled anti-human secondary antibody reagent bottle, a substrate reaction liquid reagent bottle, a stop solution reagent bottle and 3-7 preS1 antibody standard sample reagent bottles. The kit is simple to operate, is easy to operate during use, and is used for preparing reagents required by detection on site. Based on the technology of quantitatively detecting the preS1 antibody, the content of the preS1 antibody in human serum and plasma is detected, so that the method is used for finding the hepatitis B infected person in the early stage and evaluating the prognosis capability and the treatment effect of medication of the infected person.
priorityDate 2020-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453034310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520675

Total number of triples: 28.